Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
147.50
+0.50 (0.34%)
Mar 4, 2026, 10:50 AM EST - Market open
Insmed Stock Forecast
Stock Price Forecast
The 22 analysts that cover Insmed stock have a consensus rating of "Strong Buy" and an average price target of $188.73, which forecasts a 27.95% increase in the stock price over the next year. The lowest target is $115 and the highest is $241.
Price Target: $188.73 (+27.95%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Insmed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 12 | 12 | 12 |
| Buy | 7 | 7 | 9 | 10 | 9 | 9 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 19 | 21 | 24 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $211 → $204 | Buy | Maintains | $211 → $204 | +38.31% | Feb 24, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $230 | Strong Buy | Reiterates | $230 | +55.93% | Feb 23, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $234 → $208 | Buy | Maintains | $234 → $208 | +41.02% | Feb 20, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $157 → $162 | Hold | Maintains | $157 → $162 | +9.83% | Jan 30, 2026 |
| Barclays | Barclays | Buy Initiates $231 | Buy | Initiates | $231 | +56.61% | Jan 28, 2026 |
Financial Forecast
Revenue This Year
1.63B
from 606.42M
Increased by 168.46%
Revenue Next Year
2.70B
from 1.63B
Increased by 65.97%
EPS This Year
-2.93
from -6.42
EPS Next Year
0.48
from -2.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.0B | 3.8B | |||
| Avg | 1.6B | 2.7B | |||
| Low | 949.6M | 1.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 236.7% | 130.7% | |||
| Avg | 168.5% | 66.0% | |||
| Low | 56.6% | 16.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.65 | 3.59 | |||
| Avg | -2.93 | 0.48 | |||
| Low | -4.20 | -1.60 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.